Varicose Veins Show Enhanced Chemokine Expression

European Journal of Vascular and Endovascular Surgery

Volumn 38, Issue 5, 2009, Pages 635-641

  del Rio Sola L ^a   Aceves, M ^b   Duenas A I ^b   Gonzalez Fajardo J A ^a   Vaquero, C ^a   Sanchez Crespo, M ^b   Garcia Rodriguez C ^b  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^b UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Acetylsalicylic acid; Chemokine gene expression; Inflammation; Interleukin 8; Monocyte chemoattractant protein (MCP) 1; Varicose vein

Indexed keywords

ACETYLSALICYLIC ACID; CHEMOKINE; CYTOKINE; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; RIBONUCLEASE; RNA; ANTIINFLAMMATORY AGENT; ANTITHROMBOCYTIC AGENT; AUTACOID; MESSENGER RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; PATHOGENESIS; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAPHENOUS VEIN; TREATMENT OUTCOME; VARICOSIS; VASCULAR ENDOTHELIUM; DRUG ADMINISTRATION; DRUG EFFECT; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; UPREGULATION; VASCULAR SURGERY;

ADULT; ANTI-INFLAMMATORY AGENTS; ASPIRIN; CHEMOKINES; COMBINED MODALITY THERAPY; CYTOKINES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RNA, MESSENGER; SAPHENOUS VEIN; TREATMENT OUTCOME; UP-REGULATION; VARICOSE VEINS; VASCULAR SURGICAL PROCEDURES;

EID: 70449704434     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2009.07.021     Document Type: Article

References (32)

1. Eberhardt R.T., and Rafetto J.D. Chronic venous insufficiency. Circulation 111 (2005) 2398-2409
2. Bergan J.J., Schmid-Schönbein G.W., Coleridge-Smith P.D., Nicolaides A.N., Boisseau M.R., and Eklof B. Chronic venous disease. N Engl J Med 355 (2006) 488-498
3. Somers P., and Knaapen M. The Histopathology of varicose vein disease. Angiology 57 (2006) 546-555
4. Nicolaides A.N. Investigation of chronic venous insufficiency: a consensus statement. Circulation 102 (2000) e126-e163
5. Coleridge-Smith P., and Bergan J.J. Inflammation in venous disease. In: Schmid-Schönbein G., and Granger D.N. (Eds). Molecular basis for microcirculatory disorders (2003), Springer, Paris 489-513
6. Schmid-Schönbein G., Takase S., and Bergan J.J. New advances in the understanding of the pathophysiology of chronic venous insufficiency. Angiology 52 (2001) S27-S28
7. Michiels C., Arnould T., and Remacle J. Endothelial cell responses to hypoxia: initiation of a cascade of cellular interactions. Biochem Biophys Acta 1497 (2000) 1-10
8. Boisseau M. Effect of shear stress in vascular endothelial changes. Phlebolymphology 40 (2003) 143-155
9. Moazzam F., Delano F.A., Zweifach B.W., and Schmid-Schönbein G.W. The leucocyte response to fluid stress. Proc Natl Acad Sci USA 94 (1997) 13152-13157
10. Fukuda S., Yasu T., Predescu D.N., and Schmid-Schönbein G.W. Mechanisms for regulation of fluid shear stress response in circulating leucocytes. Circ Res 86 (2000) E13-E18
11. Charo I.F., and Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354 (2006) 610-621
12. Mantovani A. The chemokine system: redundancy for robust outputs. Immunol Today 20 (1999) 254-257
13. Baggiolini M. Chemokines and leucocyte traffic. Nature 392 (1998) 656-658
14. Del Río L., Caballero L., González-Fajardo J.A., Martín M., Torres A., San José I., et al. Factores pronósticos e influencia de la terapia con antiinflamatorios no esteroideos en la insuficiencia venosa crónica (IVC) grado IV. Angiología 54 (2002) 241 Abstract
15. Gloviczki P., and Yao J.S.T. Classification and grading of chronic venous disease in the lower limbs: a consensus statement. In: Gloviczki P., and Yao J.S.T. (Eds). Handbook of venous disorders. 2nd ed (2001), Arnold, London 521-525
16. Cario-Toumaniantz C., Boularan C., Schurgers L.J., Heymann M.F., Le Cunff M., Leger J., et al. Identification of differentially expressed genes in human varicose veins: involvement of matrix Gla protein in extracellular matrix remodeling. J Vasc Res 44 (2007) 444-459
17. Aceves M., Dueñas A., Gomez C., San Vicente E., Sánchez Crespo M., and Garcia-Rodriguez C. A new pharmacological effect of salicylates: inhibition of NFAT-dependent transcription. J Immunol 173 (2004) 5721-5729
18. Sayer G.L., and Smith P.D. Immunocytochemical characterization of the inflammatory cell infiltrate of varicose veins. Eur J Vasc Endovasc Surg 28 (2004) 479-483
19. Pappas P.J., Fallek F.R., Garcia A., Araki C.T., Back T.L., Duran W.N., et al. Role of leucocyte activation in patients with venous stasis ulcers. J Surg Res 59 (1995) 553-559
20. Saharay M., Shields D.A., Georgiannos S.N., Porter J.B., Scurr J.H., and Coleridge-Smith P.D. Endothelial activation in patients with chronic venous disease. Eur J Vasc Endovasc Surg 15 (1998) 342-349
21. Yamada T., Tomita S., Mori M., Sasatomi E., Suenaga E., and Ito T. Increased mast cell infiltration in varicose vein of the lower limbs: a possible role in the development of varices. Surgery 119 (1996) 494-497
22. Kakkos S.K., Zolota V.G., Peristeropoulou P., Apostolopoulou A., Geroukalos G., and Tsolakis I.A. Increased mast infiltration in familial varicose veins: pathogenic implications?. Int Angiol 22 (2003) 43-49
23. Ono T., Bergan J.J., Schmid-Shönbein G.W., and Takase S. Monocyte infiltration into venous valves. J Vasc Surg 27 (1998) 158-166
24. Whiston R.J., Hallett M.B., Davies E.V., Harding K.G., and Lane I.F. Inappropriate neutrophil activation in venous disease. Br J Surg 81 (1994) 695-698
25. Takase S., Bergan J.J., and Schmid-Shönbein G.W. Expression of adhesive molecules and cytokines on saphenous veins in chronic venous insufficiency. Ann Vasc Surg 14 (2000) 427-435
26. Peschen M., Lahaye T., Hennig B., Weyl A., Simon J.C., and Vanscheidt W. Expression of the adhesion molecules ICAM-1, VCAM-1, LFA-1 and VLA-4 in the skin is modulated in progressing stages of chronic venous insufficiency. Acta Derm Venereol 79 (1999) 27-32
27. Badier-Commander C., Couvelard A., Henin D., Verbeuren T., Michel J.B., and Jacob M.P. Smooth muscle cell modulation and cytokine overproduction in varicose veins. An in situ study. J Pathol 193 (2001) 398-407
28. Pascual G., Mendieta C., Garcia-Honduvilla N., Corrales C., Bellon J.M., and Bujan J. TGF-β1 upregulation in the aging varicose vein. J Vasc Res 44 (2007) 192-201
29. Jacob T., Hingorani A., and Ascher E. Overexpression of transforming growing factor-β1 correlates with increased synthesis of nitric oxide synthase in varicose veins. J Vasc Surg 41 (2005) 523-530
30. Jacob M.P., Cazaubon M., Scemama A., Prie D., Blanchet F., Guillin M.C., and Michel J.B. Plasma matrix metalloproteinase-9 as a marker of blood stasis in varicose veins. Circulation 106 (2002) 535-538
31. Badier-Commander C., Verbeuren T., Lebard C., Michel J.B., and Jacob M.P. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation. J Pathol 192 (2000) 105-112
32. Bergan J.J., Pascarella L., and Schmid-Schönbein G.W. Pathogenesis of primary chronic venous disease: insights from animal models of venous hypertension. J Vasc Surg 47 (2008) 183-192